SBBP Strongbridge Biopharma plc Stock Quote

SBBP [NASD]

Index	-	P/E	-	EPS (ttm)	-0.77	Insider Own	3.10%	Shs Outstand	56.11M	Perf Week	-0.34%
Market Cap	202.55M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	226.85%	Shs Float	38.15M	Perf Month	8.52%
Income	-42.10M	PEG	-	EPS next Q	-0.12	Inst Own	71.10%	Short Float	1.85%	Perf Quarter	38.86%
Sales	28.10M	P/S	7.21	EPS this Y	-242.50%	Inst Trans	-0.04%	Short Ratio	1.45	Perf Half Y	-14.33%
Book/sh	1.33	P/B	2.20	EPS next Y	11.50%	ROA	-38.80%	Target Price	-	Perf Year	-3.62%
Cash/sh	-	P/C	-	EPS next 5Y	20.00%	ROE	-65.80%	52W Range	1.50 - 4.63	Perf YTD	20.58%
Dividend	-	P/FCF	-	EPS past 5Y	-16.70%	ROI	-95.40%	52W High	-36.72%	Beta	1.75
Dividend %	-	Quick Ratio	4.50	Sales past 5Y	-	Gross Margin	90.20%	52W Low	95.33%	ATR	0.17
Employees	71	Current Ratio	4.50	Sales Q/Q	42.10%	Oper. Margin	-	RSI (14)	57.46	Volatility	5.23% 6.17%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	77.90%	Profit Margin	-	Rel Volume	0.85	Prev Close	2.89
Shortable	Yes	LT Debt/Eq	0.10	Earnings	Oct 29 AMC	Payout	-	Avg Volume	486.71K	Price	2.93
Recom	1.50	SMA20	6.20%	SMA50	8.79%	SMA200	-0.41%	Volume	413,485	Change	1.38%

Mar-03-20

Initiated

Craig Hallum

Buy

$7.50

Sep-25-19

Initiated

Evercore ISI

Outperform

Sep-24-19

Initiated

Jefferies

Buy

Dec-18-18

Initiated

Laidlaw

Buy

$11

Dec-06-17

Initiated

Cantor Fitzgerald

Buy

$14

Jan-25-17

Reiterated

H.C. Wainwright

Buy

$15 → $18

Apr-25-16

Initiated

H.C. Wainwright

Buy

$15

Nov-10-15

Initiated

Stifel

Buy

$21

Nov-10-15

Initiated

JMP Securities

Mkt Outperform

Jan-06-21 07:00AM	Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update GlobeNewswire +7.69%
Jan-04-21 03:29AM	Is Strongbridge Biopharma (NASDAQ:SBBP) Using Debt Sensibly? Simply Wall St.
Dec-14-20 09:56AM	Is SBBP A Good Stock To Buy Now? Insider Monkey +6.54%
Nov-24-20 07:30AM	Strongbridge Biopharma plc Announces Publication of Secondary Endpoints Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome in the Journal, Pituitary GlobeNewswire
Nov-12-20 07:30AM	Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences GlobeNewswire
Nov-10-20 12:42PM	Oppenheimer Sees These 3 Stocks Skyrocketing Over 100% TipRanks +9.05%
Nov-03-20 11:52AM	A Look At Strongbridge Biopharma's (NASDAQ:SBBP) Share Price Returns Simply Wall St.
Oct-29-20 05:35PM	Strongbridge Biopharma (SBBP) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
03:00PM	Strongbridge Biopharma Plcto Host Earnings Call ACCESSWIRE
Oct-22-20 07:30AM	Strongbridge Biopharma plc to Host Third Quarter 2020 Financial Results Conference Call on October 29, 2020 GlobeNewswire
Sep-30-20 06:05PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP ACCESSWIRE
Sep-28-20 10:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP ACCESSWIRE
Sep-27-20 01:08AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP GlobeNewswire
Sep-23-20 10:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP ACCESSWIRE
Sep-21-20 09:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP ACCESSWIRE
Sep-19-20 05:14PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP GlobeNewswire
Sep-17-20 08:00AM	Strongbridge Biopharma plc Investors: Company Investigated by the Portnoy Law Firm GlobeNewswire -20.36%
Sep-16-20 11:29PM	Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares GlobeNewswire
04:35PM	Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares GlobeNewswire
01:05PM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Strongbridge Biopharma plc (SBBP) Investigation ACCESSWIRE
Sep-14-20 08:32PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP PR Newswire +9.80%
11:00AM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Strongbridge Biopharma plc (SBBP) Investigation ACCESSWIRE
Sep-08-20 08:00AM	Strongbridge Biopharma plc Provides Corporate Update GlobeNewswire -20.11%
06:30AM	Strongbridge Biopharma plc Announces Positive and Statistically Significant Top-Line Results from the Pivotal Phase 3 LOGICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome GlobeNewswire
Aug-28-20 01:37PM	What Type Of Shareholders Own The Most Number of Strongbridge Biopharma plc (NASDAQ:SBBP) Shares? Simply Wall St.
Aug-04-20 09:05AM	Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates Zacks +13.45%
07:30AM	Strongbridge Biopharma plc Reports Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Jul-28-20 07:30AM	Strongbridge Biopharma plc to Host Second Quarter 2020 Financial Results Conference Call on August 4, 2020 GlobeNewswire
Jul-22-20 12:32PM	Will Strongbridge Biopharma (SBBP) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-07-20 07:30AM	Strongbridge Biopharma plc Announces Appointment of John H. Johnson to Chief Executive Officer GlobeNewswire
Jul-05-20 10:26PM	Hedge Funds Are Crazy About Strongbridge Biopharma plc (SBBP) Insider Monkey
Jul-01-20 07:30AM	Strongbridge Biopharma plc Announces Last Patient Completes Last Study Visit in the Randomized Withdrawal Phase of the LOGICS Trial Evaluating RECORLEV® (levoketoconazole) for Endogenous Cushings Syndrome GlobeNewswire
Jun-01-20 07:30AM	Strongbridge Biopharma plc to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-27-20 11:34AM	We're Hopeful That Strongbridge Biopharma (NASDAQ:SBBP) Will Use Its Cash Wisely Simply Wall St.
May-20-20 07:30AM	Strongbridge Biopharma plc Announces $30 Million Debt Facility with Avenue Venture Opportunities Fund, L.P. GlobeNewswire
May-18-20 10:04AM	2 Biotech Stocks Under $5 With Blockbuster Potential TipRanks +9.44%
07:30AM	Strongbridge Biopharma plc to Present at Upcoming 2020 Solebury Trout Virtual Global Healthcare Conference Series GlobeNewswire
May-15-20 06:33AM	Edited Transcript of SBBP earnings conference call or presentation 6-May-20 12:30pm GMT Thomson Reuters StreetEvents
May-11-20 07:30AM	Strongbridge Biopharma plc Announces Completion of Enrollment of Phase 3 LOGICS Study for RECORLEV® (levoketoconazole) for Endogenous Cushings Syndrome GlobeNewswire +11.54%
May-06-20 09:35AM	Strongbridge Biopharma (SBBP) Reports Q1 Loss, Tops Revenue Estimates Zacks +9.58%
08:25AM	Recap: Strongbridge Biopharma Q1 Earnings Benzinga
07:30AM	Strongbridge Biopharma plc Reports First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Apr-29-20 12:34PM	Will Strongbridge Biopharma (SBBP) Report Negative Earnings Next Week? What You Should Know Zacks +14.40%
Apr-20-20 07:30AM	Strongbridge Biopharma plc to Host First Quarter 2020 Financial Results Conference Call on May 6, 2020 GlobeNewswire
Mar-07-20 12:26AM	Edited Transcript of SBBP earnings conference call or presentation 25-Feb-20 1:30pm GMT Thomson Reuters StreetEvents
Feb-27-20 08:35AM	If You Had Bought Strongbridge Biopharma (NASDAQ:SBBP) Shares Five Years Ago You'd Have Made 139% Simply Wall St.
07:30AM	Strongbridge Biopharma plc to Present at the Cowen and Company 40th Annual Healthcare Conference GlobeNewswire
Feb-25-20 08:55AM	Strongbridge Biopharma (SBBP) Reports Q4 Loss, Tops Revenue Estimates Zacks -13.68%
07:30AM	Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update GlobeNewswire
06:30AM	Strongbridge Biopharma Plc to Host Earnings Call ACCESSWIRE
Feb-19-20 07:30AM	Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 25, 2020 GlobeNewswire
Jan-30-20 04:30PM	Strongbridge Biopharma plc Announces New Employment Inducement Awards GlobeNewswire -8.25%
Jan-09-20 07:30AM	Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results and Provides Update on Corporate Priorities GlobeNewswire +6.19%
Dec-16-19 07:35AM	Should You Avoid Strongbridge Biopharma plc (SBBP)? Insider Monkey
Nov-18-19 01:03PM	Bucks County biopharm firm makes more job cuts American City Business Journals -6.96%
07:30AM	Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent Director GlobeNewswire
Nov-17-19 09:25AM	Edited Transcript of SBBP earnings conference call or presentation 7-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 07:30AM	Strongbridge Biopharma plc to Present at Two Upcoming Investor Conferences GlobeNewswire
Nov-07-19 09:05AM	Strongbridge Biopharma (SBBP) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:30AM	Strongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Nov-06-19 08:21AM	The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings Benzinga +13.21%
Nov-05-19 03:32PM	Bucks County biopharma firm's CEO departs American City Business Journals -34.30%
06:30AM	Strongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate Updates GlobeNewswire
Oct-31-19 10:33AM	Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-29-19 07:30AM	Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019 GlobeNewswire
Oct-23-19 10:33AM	Will Strongbridge Biopharma (SBBP) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-17-19 07:30AM	Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting GlobeNewswire
Sep-25-19 09:04AM	Strongbridge Biopharma plc to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-19-19 07:30AM	Strongbridge Biopharma plc Announces RECORLEV (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology GlobeNewswire
Sep-03-19 07:30AM	Strongbridge Biopharma plc to Present at the H.C. Wainwright 21st Annual Global Investment Conference and the Janney Montgomery Scott Healthcare Conference 2019 GlobeNewswire
Aug-21-19 10:12PM	Edited Transcript of SBBP earnings conference call or presentation 31-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-13-19 08:45AM	Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth GlobeNewswire
Jul-31-19 09:15AM	Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:30AM	Strongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Jul-24-19 07:30AM	Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019 GlobeNewswire
Jul-19-19 07:30AM	Strongbridge Biopharma plc Announces New Employment Inducement Awards GlobeNewswire
Jul-11-19 06:40AM	Is Strongbridge Biopharma plc's (NASDAQ:SBBP) ROE Of 43% Impressive? Simply Wall St.
Jul-01-19 07:30AM	Strongbridge Biopharma plc Added to the Russell 3000® and Microcap® Indexes GlobeNewswire +7.99%
Jun-23-19 04:11PM	Heres What Hedge Funds Think About Strongbridge Biopharma plc (SBBP) Insider Monkey
Jun-12-19 07:30AM	Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference GlobeNewswire +5.00%
Jun-04-19 07:30AM	Strongbridge Biopharma plc Strengthens Senior Leadership Team with Key Promotion and Appointment GlobeNewswire
May-30-19 07:30AM	Strongbridge Biopharma plc to Present at the Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-09-19 04:05PM	Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Academy of Neurology Annual Meeting GlobeNewswire -5.46%
May-06-19 05:24PM	Edited Transcript of SBBP earnings conference call or presentation 1-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-04-19 11:14PM	Edited Transcript of SBBP earnings conference call or presentation 26-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
May-02-19 12:23AM	Strongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript Motley Fool
May-01-19 01:16PM	Strongbridge Biopharma (SBBP) Reports Q1 Loss, Lags Revenue Estimates Zacks -20.88%
11:12AM	Strongbridge Biopharma plc (SBBP) Q1 2019 Earnings Call Transcript Motley Fool
07:30AM	Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Apr-26-19 09:43AM	News Surrounds 3 Small Biotechs, With a Merger Claiming One TheStreet.com
08:02AM	The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug Benzinga
Apr-25-19 04:01PM	Strongbridge Biopharma plc Announces Presentation of New Secondary Endpoint Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 American Association of Clinical Endocrinologists Annual Scientific and Clinical Congress GlobeNewswire
Apr-24-19 07:30AM	Strongbridge Biopharma plc to Host First Quarter 2019 Financial Results Conference Call on May 1, 2019 GlobeNewswire
Apr-18-19 10:13AM	Does Strongbridge Biopharma plc's (NASDAQ:SBBP) CEO Pay Compare Well With Peers? Simply Wall St.
Apr-15-19 07:30AM	Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 American Association of Clinical Endocrinologists (AACE) Annual Scientific and Clinical Congress GlobeNewswire
Mar-25-19 07:30AM	Strongbridge Biopharma plc Announces Presentation of New Data Analyses from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Potential Treatment of Endogenous Cushings Syndrome GlobeNewswire -6.99%
Mar-11-19 12:36PM	Is Strongbridge Biopharma plc (NASDAQ:SBBP) Potentially Underrated? Simply Wall St. +9.09%
07:30AM	Strongbridge Biopharma plc Announces Top-Line Results from Extended Evaluation Phase of the Pivotal Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Potential Treatment of Endogenous Cushings Syndrome GlobeNewswire
Mar-08-19 07:30AM	Strongbridge Biopharma plc Announces New Employment Inducement Awards GlobeNewswire

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GILL DAVID N	Director	Sep 24	Buy	2.13	8,000	17,040	74,896	Sep 28 07:48 AM
CDK ASSOCIATES, L.L.C.	10% Owner	Sep 18	Buy	2.20	6,000	13,200	8,060,682	Sep 21 09:48 PM
CDK ASSOCIATES, L.L.C.	10% Owner	Sep 17	Buy	2.25	1,473,377	3,315,098	8,054,682	Sep 21 09:48 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience